文献速递物质与行为成瘾心境障碍焦虑、强迫与应激相关障碍

美国新冠疫情期间孕产期药物过量死亡趋势

Pregnancy and Postpartum Drug Overdose Deaths in the US Before and During the COVID-19 Pandemic.
PubMed 文献 · JAMA Psychiatry · 2024-01-01

结果显示孕产期药物过量死亡率比值持续上升,35至44岁孕产妇死亡率比值从2018年上半年的4.9增至2021年下半年的15.8,且多数孕产期药物过量死亡发生在医疗场所之外。

要点

  • 2018至2021年孕产期药物过量死亡率比值持续上升,35至44岁孕产妇死亡率比值从4.9增至15.8。
  • 孕产期药物过量死亡者较产科死亡者更年轻、受教育程度更低、未婚比例更高。
  • 多数孕产期药物过量死亡发生在非家庭且非医疗场所,提示需加强社区外展和孕产妇医疗支持。

核心结论

  • 2018至2021年美国孕产期药物过量死亡率比值持续上升,35至44岁孕产妇死亡率比值增加超过三倍。
  • 多数孕产期药物过量死亡发生在医疗场所之外,需加强社区外展和孕产妇医疗支持。
  • 减少孕产期药物过量死亡需在个体、医疗、地方和国家层面采取循证干预及非惩罚性措施。

研究设计与样本

  • 数据来源于2018至2021年多重死因档案,链接2021年地区卫生资源档案和2018至2021年县健康排名数据。
  • 孕产期死亡定义为妊娠期间或妊娠终止后1年内发生的死亡,聚焦于涉及常见滥用精神药物的非故意药物过量或意图不明的药物过量。

主要发现

  • 2018至2021年孕产期药物过量死亡率比值在10至44岁女性中持续上升。
  • 35至44岁孕产妇死亡率比值从2018年1至6月的4.9(95%CI,3.0-8.0)/10万活产增至2021年7至12月的15.8(95%CI,12.3-20.4),平均半年百分比变化为15.9(95%CI,8.7-23.6;P<.001)。
  • 与产科死亡者相比,孕产期药物过量死亡者更可能为10至34岁(75.4% vs 59.5%;OR范围从10至24岁的1.8[95%CI,1.3-2.5]到25至34岁的2.2[95%CI,1.7-2.8])。
  • 孕产期药物过量死亡者更可能为非大学毕业生(72.1% vs 59.4%;OR范围从部分大学教育的2.7[95%CI,1.7-4.3]到高中以下的3.9[95%CI,2.4-6.1])、未婚(88.0% vs 62.1%;OR,4.5;95%CI,3.7-6.0)。
  • 孕产期药物过量死亡者更可能死于非家庭非医疗场所(25.9% vs 4.5%;OR,2.5;95%CI,1.8-3.6),死于医疗场所的比值更低(34.7% vs 77.6%;OR范围从住院的0.1[95%CI,0.1-0.1]到门诊/急诊的0.4[95%CI,0.3-0.6])。

临床怎么用

  • 应加强社区外展和孕产妇医疗支持,以覆盖发生在医疗场所之外的孕产期药物过量死亡。
  • 需在个体、医疗、地方和国家层面实施循证干预,并采用非惩罚性措施鼓励孕产期女性寻求物质使用障碍治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Knowledge about characteristics of US pregnancy-associated decedents is needed to guide responses. OBJECTIVE: To examine individual sociodemographic characteristics and residing county's health care resources and socioeconomic factors among pregnancy-associated overdose decedents in comparison with obstetric decedents and overdose decedents who were not pregnant in the past year. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional, exploratory study included 1457 pregnant and postpartum overdose decedents, 4796 obstetric decedents, and 11 205 nonpregnant overdose decedents aged 10 to 44 years from 2018 to 2021. Data were analyzed August 2023. EXPOSURES: Decedents from the 2018-2021 Multiple Cause of Death Files linked to the 2021 Area Health Resources Files and the 2018-2021 County Health Rankings data at the county level. MAIN OUTCOMES AND MEASURES: Pregnancy-associated deaths were defined as deaths during pregnancy or within 1 year of pregnancy termination. This study focused on unintentional drug overdoses or drug overdoses with undetermined intent involving the most common psychotropic drugs of misuse. RESULTS: From 2018 to 2021, across the pregnancy-postpartum continuum, pregnancy-associated overdose mortality ratios consistently increased among women aged 10 to 44 years. Mortality ratio more than tripled among pregnant and postpartum women aged 35 to 44 years from 4.9 (95% CI, 3.0-8.0) per 100 000 mothers aged 35 to 44 years with a live birth in January to June 2018 to 15.8 (95% CI, 12.3-20.4) in July to December 2021 (average semiannual percentage changes, 15.9; 95% CI, 8.7-23.6; P < .001). Compared with pregnant obstetric decedents, pregnant overdose decedents had increased odds of being aged 10 to 34 years (75.4% vs 59.5%; range of odds ratios [ORs], 1.8 [95% CI, 1.3-2.5] for ages 10 to 24 years to 2.2 [95% CI, 1.7-2.8] for ages 25 to 34 years), being non-college graduates (72.1% vs 59.4%; range of ORs, 2.7 [95% CI, 1.7-4.3] for those with some college education to 3.9 [95% CI, 2.4-6.1] for those with less than high school education), being unmarried (88.0% vs 62.1%; OR, 4.5; 95% CI, 3.7-6.0), and dying in nonhome, non-health care settings (25.9% vs 4.5%; OR, 2.5; 95% CI, 1.8-3.6) and were associated with decreased odds of dying in health care settings (34.7% vs 77.6%; range of ORs, 0.1 [95% CI, 0.1-0.1] for those who died in hospital inpatient settings to 0.4 [95% CI, 0.3-0.6] for those who died in hospital outpatient/emergency room settings). CONCLUSIONS AND RELEVANCE: From 2018 to 2021, the mortality ratio more than tripled among pregnant and postpartum women aged 35 to 44 years, consistent with increases in overdose mortality across US populations. Most pregnancy-associated overdose deaths occurred outside health care settings, indicating the need for strengthening community outreach and maternal medical support. To reduce pregnancy-associated overdose mortality, evidence-based interventions are urgently needed at individual, health care, local, and national levels, along with nonpunitive approaches incentivizing pregnant and postpartum women to seek substance use disorder treatments.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Han B, Compton WM, Einstein EB, et al. Pregnancy and Postpartum Drug Overdose Deaths in the US Before and During the COVID-19 Pandemic. JAMA Psychiatry. 2024. PMID: 37991773. doi:10.1001/jamapsychiatry.2023.4523

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。